Search
Edgewise Therapeutics Inc
EWTXAdd to Watchlist
40.630USD
-0.290-0.71%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
4.37BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
12
analysts
Buy
Current Rating
47.727
Target Price
+16.64%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Edgewise Therapeutics Inc
EWTX
12
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Edgewise Therapeutics Inc's price target?
Analysts forecast that Edgewise Therapeutics Inc's price target is USD 41.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 14.00.
How have Edgewise Therapeutics IncEWTX's recent earnings per share performed?
The market expectation was USD -0.46, while Edgewise Therapeutics IncEWTX's earnings per share (EPS) for the previous quarter was USD -0.47. EPS for the next quarter is expected at USD -0.47.
What is the analyst rating for Edgewise Therapeutics Inc?
Based on the ratings of Edgewise Therapeutics Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.